结合
化学
效力
立体化学
雌激素受体
细胞毒性
结构-活动关系
癌细胞系
化学合成
组合化学
细胞毒性T细胞
烷基
药效团
对接(动物)
MCF-7型
癌细胞
雌激素受体α
乳腺癌
铅化合物
分子模型
生物活性
药理学
细胞培养
生物化学
药品
体外
数量结构-活动关系
连接器
雌激素受体
体内
人体乳房
细胞生长
雌激素
肿瘤细胞
癌症
阳性对照
作者
Anu Saini,Sumit Kumar,Mandeep Kaur,Sourav Taru Saha,Raghu Raj,Vipan Kumar
摘要
A series of 4-aminoquinoline analogues and 4-aminoquinoline-benzoxaborole conjugates were synthesized and evaluated for their antiproliferative activities against two distinct breast cancer cell lines: MCF-7 (estrogen receptor-positive, ER+) and MDA-MB-231 (triple-negative). Preliminary dose-response assays revealed compound 5e, a 4-aminoquinoline-benzoxaborole conjugate, as the most active compound against MCF-7 cells. Structure-activity relationship (SAR) analysis indicated that the cytotoxic potency of the series increased with the length of the alkyl spacer connecting the pharmacophoric moieties. To assess selectivity, HEK-293 cells were employed as a non-cancerous control line, and most compounds exhibited minimal cytotoxicity, except compound 5d, which showed moderate effects. To gain preliminary structural insights, exploratory molecular docking studies were performed against the ligand-binding domain of estrogen receptor alpha (ERα). This integrated experimental-computational approach highlights the identification of promising preliminary hits. Overall, the findings show that 4-aminoquinoline-benzoxaborole conjugates exhibit antiproliferative activity against breast cancer cells, with greater potency towards MCF-7 cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI